Challenges
Datasets
Workspaces
Papers
Discussions
Leaderboard
Log inSign up
Challenges
Datasets
Workspaces
Papers
Discussions
Leaderboard
Blog
Job Board
Q3AS

© 2026 Aqora Quantum S.A.S.

TermsPrivacyLegal Notice

Advances in computational intelligence and robotics book series

Next Generation Drug Discovery Through Quantum-Enhanced Molecular Analysis

Vikas Sharma, Vivek Kumar, Vineeta Singh, Ritesh Rastogi, Alok Kumar, Mohd. Shah Alam

Published Nov 5, 2026• 0 citations
Publisher

Abstract

The pharmaceutical sector faces escalating challenges in discovering feasible treatment agents, expediting research timelines, and enhancing the overall success rate of new drug initiatives. Emerging as a transformative technology, quantum computer technology offers innovative opportunities for addressing these problems through superior molecular modelling, simulation, and optimization capabilities relative to classical computational methods. This chapter will examine the contributions of quantum technology to the future development of new medicines. Using various quantum algorithms, an improved understanding of molecular structure, protein–ligand interactions, reaction kinetics, and the dynamics of biomolecules will allow improved prediction of drug behaviour and efficacy. In addition, this chapter will address the combined use of AI, quantum simulation and computational chemistry to increase speed around target identification; virtual screening; lead optimizing; and personalizing medicine creation.

DOI
10.4018/979-8-2600-0482-1.ch011

Related papers

Exploring the Potential of Quantum Computing for Drug Design

Surbhi Kamboj, Gorika Tomar, Archana Archana +5 more

Quantum AI, the integration of quantum computing and artificial intelligence, is revolutionizing drug design by addressing the limitations of traditional pharmaceutical development. This review explores its transformative potential in enhancing molecular simulations, structure-based, target-based, and ligand-based drug discovery, and personalized medicine. Quantum computing leverages principles like superposition, entanglement, and interference to perform complex calculations exponentially faster than classical systems, enabling precise modeling of molecular interactions. Algorithms such as the Variational Quantum Eigensolver (VQE) and Quantum Phase Estimation (QPE) outperform classical methods like Density Functional Theory (DFT) in accuracy and efficiency, facilitating the identification of promising drug candidates and optimizing their pharmacokinetic properties. Quantum AI also enhances personalized medicine by analyzing vast genomic datasets to tailor treatments, improving efficacy and minimizing adverse effects. Despite challenges, including noisy intermediate-scale quantum (NISQ) device limitations and the need for advanced error correction, ongoing research and interdisciplinary collaboration are driving progress. Quantum AI promises to reduce development costs, accelerate drug discovery, and democratize access to life-saving medications. By enabling simulation-based discovery and expanding drug-candidate libraries to include peptides and antibodies, it paves the way for breakthroughs in treating complex diseases. This review underscores the need for continued investment in quantum technology to fully harness its potential, positioning the pharmaceutical industry for a future where drug development is faster, more precise, and patient-centric, ultimately improving global healthcare outcomes.

Journal of Neonatal Surgery•May 9, 2025•0 citations

Quantum Computing's Future Role in AI-Driven Drug Discovery

Kartheek Sankranthi

Quantum computing is poised to revolutionize pharmaceutical research through its integration with artificial intelligence for drug discovery applications. This article examines how quantum computational approaches address fundamental limitations in traditional drug development pipelines, particularly in molecular modeling and simulation, where classical computing faces exponential scaling challenges. By leveraging quantum mechanical phenomena like superposition and entanglement, quantum algorithms such as the Variational Quantum Eigen solver and the Quantum Approximate Optimization Algorithm offer unprecedented accuracy for simulating protein-ligand interactions and predicting molecular behavior. Strategic industry partnerships between quantum technology companies and pharmaceutical giants are establishing frameworks to translate theoretical quantum advantages into practical applications. The synergistic relationship between AI's pattern recognition capabilities and quantum computing's physical simulation prowess creates a powerful paradigm for accelerating drug development while reducing costs. Applications extend to personalized medicine, where quantum approaches enable the analysis of complex genomic datasets to optimize treatments for individual genetic profiles. While technical challenges persist, the trajectory toward quantum-enhanced drug discovery is clear, with significant benefits anticipated as quantum hardware capabilities continue to advance.

World Journal of Advanced Research and Reviews•May 17, 2025•1 citation

Quantum Computing and AI: Transforming the Future of Drug Discovery and Development

Lovely Chaurasia, Shikha Parmar, Shivani Sharma, Archana Sharma, Renu Virk, Ajay Dixit, Meenakshi Tyagi

The integration of quantum computing and artificial intelligence (AI), collectively termed Quantum AI, is revolutionizing the pharmaceutical industry by reshaping the paradigms of drug discovery and development. Traditional approaches to drug design are often limited by high costs, extensive timelines, and the computational intractability of simulating complex molecular interactions. Quantum computing offers exponential processing power, enabling the accurate modeling of quantum-level chemical phenomena that classical computers struggle to handle. Concurrently, AI contributes by enhancing data interpretation, prediction of molecular behaviors, and pattern recognition across large biological datasets. Together, Quantum AI enables faster identification of drug candidates, improved simulation of drug-target interactions, and early prediction of pharmacokinetics and toxicity. Key quantum algorithms, such as the Variational Quantum Eigensolver (VQE) and quantum-enhanced machine learning, have demonstrated potential to outperform conventional methods in quantum chemical calculations. Moreover, this synergy facilitates personalized medicine by integrating patient-specific data to optimize therapeutic outcomes. Despite current challenges related to hardware scalability, algorithm optimization, and ethical integration, the future trajectory of Quantum AI is poised to redefine pharmaceutical innovation. This review underscores the transformative capabilities of Quantum AI and its potential to usher in a new era of efficient, cost-effective, and precision-driven drug development.

International Journal of Environmental Sciences•Aug 11, 2025•0 citations

Quantum Computing in Drug Discovery Techniques, Challenges, and Emerging Opportunities

Gomase VS, Arjun P. Ghatule, Rupali Sharma +1 more

INTRODUCTION: Quantum computing represents a transformative advancement in computational science, with applications in drug discovery, molecular interaction simulation, drug-target binding optimization, and the analysis of complex biological data at unprecedented speeds and accuracy. Quantum computing emerges as a powerful tool to accelerate the development of new therapeutics, drug design, and the simulation of complex chemical interactions, including personalized medicine strategies. The objective of this study is to explore the potential of quantum computing in drug discovery and development, highlighting its ability to reduce time and costs while accelerating the identification of promising drug candidates. METHODS: Quantum computing algorithms, such as Grover's algorithm and the Variational Quantum Eigensolver (VQE), are utilized to simulate molecular interactions of drugs and optimize drug design. In case studies, such as IBM's use of VQE for molecular simulations, these technologies demonstrate their effectiveness. RESULTS: Quantum computing has shown promise in addressing several technological barriers, such as lengthy development timelines and high costs. Additionally, demonstrated success in molecular simulations and solving challenges during the drug development process. However, challenges related to error rates, qubit coherence, and regulatory compliance remain. DISCUSSION: This study examines the applications of quantum computing in drug discovery, highlighting key techniques such as quantum simulation, quantum machine learning, and optimization algorithms. Quantum computing is crucial for interdisciplinary collaboration among quantum physicists, computational chemists, biologists, and pharmaceutical professionals, as it is essential to overcoming these obstacles and realizing the full potential of quantum technologies in medicine. CONCLUSION: Quantum computing holds great potential in drug discovery and development, offering accelerated, more accurate, and lower-cost research avenues, particularly in complex areas such as protein folding prediction and personalized medicine. This new paradigm has tremendous potential for guiding the future of pharmaceutical development and patient-focused medicine.

Current Drug Discovery Technologies•Sep 1, 2025•6 citations

Quantum Computing: Unlocking the Future of Pharmaceutical Research and Drug Discovery

Mujibullah Sheikh, Pranita Jirvankar

Quantum computing is currently recognized as a very effective instrument that helps in the advancement of pharma and speeds up the discovery of new drugs. The article discusses several ways in which quantum computing is driving innovation. Quantum mechanical calculations based molecular modeling and simulation techniques can foresee the molecular interactions and behaviors in a much faster ways and can help to identify the new phase of drug candidates. The pharmacophore modeling techniques include the structure based and ligand-based uses quantum computing in the formulation of pharmacophore models that are used in screening of libraries of compounds. Discovery of large databases of bioactive agents has been accelerated with high-throughput virtual screening utilizing quantum computing when determining further development priorities. Artificial intelligence and machine learning programs can take large data sets and determine patterns and correlations that help predict the properties of compounds and their biological activity. Molecular calculations derived from quantum mechanics give better approximations of noncovalent interactions and other quantum entities which are important in drug-target binding. The use of quantum computing to incorporate the methods of molecular dynamics simulations and QSAR analysis is empowering developments in pharmaceutical research. The review also overviews the modern concerns and possible opportunities of using quantum computing for the optimization of the drug discovery and development. All in all, the article presents a contingency of how this new and innovative technology is shaping the field of pharmaceutical research.

International Journal of Drug Delivery Technology•Mar 25, 2025•2 citations

Quantum Computing in Drug Discovery: Revolutionizing Pharmaceutical Research

Anandhavalli Muniasamy

The integration of quantum computing in drug discovery has the potential to revolutionize pharmaceutical research by significantly enhancing molecular simulations, drug screening, and optimization processes. Traditional computational methods often struggle with the complexity of molecular interactions, leading to high costs and extended timelines in drug development. Quantum computing, with its ability to process complex calculations exponentially faster than classical computers, offers innovative solutions to these challenges. This chapter explores the fundamentals of quantum computing, its application in pharmaceutical research, and real-world case studies from leading organizations. It also discusses existing challenges, potential solutions, and future directions for adopting quantum computing in drug discovery. By addressing key technical, ethical, and regulatory aspects, this chapter provides a comprehensive analysis of how quantum technologies can accelerate and optimize the drug discovery pipeline.

IGI Global eBooks•Jul 11, 2025•8 citations
The pharmaceutical sector faces escalating challenges in discovering feasible treatment agents, expediting research timelines, and enhancing the overall success rate of new drug initiatives. Emerging as a transformative technology, quantum computer technology offers innovative opportunities for addressing these problems through superior molecular modelling, simulation, and optimization capabilities relative to classical computational methods. This chapter will examine the contributions of quantum technology to the future development of new medicines. Using various quantum algorithms, an improved understanding of molecular structure, protein–ligand interactions, reaction kinetics, and the dynamics of biomolecules will allow improved prediction of drug behaviour and efficacy. In addition, this chapter will address the combined use of AI, quantum simulation and computational chemistry to increase speed around target identification; virtual screening; lead optimizing; and personalizing medicine creation.
Quantum AI, the integration of quantum computing and artificial intelligence, is revolutionizing drug design by addressing the limitations of traditional pharmaceutical development. This review explores its transformative potential in enhancing molecular simulations, structure-based, target-based, and ligand-based drug discovery, and personalized medicine. Quantum computing leverages principles like superposition, entanglement, and interference to perform complex calculations exponentially faster than classical systems, enabling precise modeling of molecular interactions. Algorithms such as the Variational Quantum Eigensolver (VQE) and Quantum Phase Estimation (QPE) outperform classical methods like Density Functional Theory (DFT) in accuracy and efficiency, facilitating the identification of promising drug candidates and optimizing their pharmacokinetic properties. Quantum AI also enhances personalized medicine by analyzing vast genomic datasets to tailor treatments, improving efficacy and minimizing adverse effects. Despite challenges, including noisy intermediate-scale quantum (NISQ) device limitations and the need for advanced error correction, ongoing research and interdisciplinary collaboration are driving progress. Quantum AI promises to reduce development costs, accelerate drug discovery, and democratize access to life-saving medications. By enabling simulation-based discovery and expanding drug-candidate libraries to include peptides and antibodies, it paves the way for breakthroughs in treating complex diseases. This review underscores the need for continued investment in quantum technology to fully harness its potential, positioning the pharmaceutical industry for a future where drug development is faster, more precise, and patient-centric, ultimately improving global healthcare outcomes.
Quantum computing is poised to revolutionize pharmaceutical research through its integration with artificial intelligence for drug discovery applications. This article examines how quantum computational approaches address fundamental limitations in traditional drug development pipelines, particularly in molecular modeling and simulation, where classical computing faces exponential scaling challenges. By leveraging quantum mechanical phenomena like superposition and entanglement, quantum algorithms such as the Variational Quantum Eigen solver and the Quantum Approximate Optimization Algorithm offer unprecedented accuracy for simulating protein-ligand interactions and predicting molecular behavior. Strategic industry partnerships between quantum technology companies and pharmaceutical giants are establishing frameworks to translate theoretical quantum advantages into practical applications. The synergistic relationship between AI's pattern recognition capabilities and quantum computing's physical simulation prowess creates a powerful paradigm for accelerating drug development while reducing costs. Applications extend to personalized medicine, where quantum approaches enable the analysis of complex genomic datasets to optimize treatments for individual genetic profiles. While technical challenges persist, the trajectory toward quantum-enhanced drug discovery is clear, with significant benefits anticipated as quantum hardware capabilities continue to advance.
The integration of quantum computing and artificial intelligence (AI), collectively termed Quantum AI, is revolutionizing the pharmaceutical industry by reshaping the paradigms of drug discovery and development. Traditional approaches to drug design are often limited by high costs, extensive timelines, and the computational intractability of simulating complex molecular interactions. Quantum computing offers exponential processing power, enabling the accurate modeling of quantum-level chemical phenomena that classical computers struggle to handle. Concurrently, AI contributes by enhancing data interpretation, prediction of molecular behaviors, and pattern recognition across large biological datasets. Together, Quantum AI enables faster identification of drug candidates, improved simulation of drug-target interactions, and early prediction of pharmacokinetics and toxicity. Key quantum algorithms, such as the Variational Quantum Eigensolver (VQE) and quantum-enhanced machine learning, have demonstrated potential to outperform conventional methods in quantum chemical calculations. Moreover, this synergy facilitates personalized medicine by integrating patient-specific data to optimize therapeutic outcomes. Despite current challenges related to hardware scalability, algorithm optimization, and ethical integration, the future trajectory of Quantum AI is poised to redefine pharmaceutical innovation. This review underscores the transformative capabilities of Quantum AI and its potential to usher in a new era of efficient, cost-effective, and precision-driven drug development.
INTRODUCTION: Quantum computing represents a transformative advancement in computational science, with applications in drug discovery, molecular interaction simulation, drug-target binding optimization, and the analysis of complex biological data at unprecedented speeds and accuracy. Quantum computing emerges as a powerful tool to accelerate the development of new therapeutics, drug design, and the simulation of complex chemical interactions, including personalized medicine strategies. The objective of this study is to explore the potential of quantum computing in drug discovery and development, highlighting its ability to reduce time and costs while accelerating the identification of promising drug candidates. METHODS: Quantum computing algorithms, such as Grover's algorithm and the Variational Quantum Eigensolver (VQE), are utilized to simulate molecular interactions of drugs and optimize drug design. In case studies, such as IBM's use of VQE for molecular simulations, these technologies demonstrate their effectiveness. RESULTS: Quantum computing has shown promise in addressing several technological barriers, such as lengthy development timelines and high costs. Additionally, demonstrated success in molecular simulations and solving challenges during the drug development process. However, challenges related to error rates, qubit coherence, and regulatory compliance remain. DISCUSSION: This study examines the applications of quantum computing in drug discovery, highlighting key techniques such as quantum simulation, quantum machine learning, and optimization algorithms. Quantum computing is crucial for interdisciplinary collaboration among quantum physicists, computational chemists, biologists, and pharmaceutical professionals, as it is essential to overcoming these obstacles and realizing the full potential of quantum technologies in medicine. CONCLUSION: Quantum computing holds great potential in drug discovery and development, offering accelerated, more accurate, and lower-cost research avenues, particularly in complex areas such as protein folding prediction and personalized medicine. This new paradigm has tremendous potential for guiding the future of pharmaceutical development and patient-focused medicine.
Quantum computing is currently recognized as a very effective instrument that helps in the advancement of pharma and speeds up the discovery of new drugs. The article discusses several ways in which quantum computing is driving innovation. Quantum mechanical calculations based molecular modeling and simulation techniques can foresee the molecular interactions and behaviors in a much faster ways and can help to identify the new phase of drug candidates. The pharmacophore modeling techniques include the structure based and ligand-based uses quantum computing in the formulation of pharmacophore models that are used in screening of libraries of compounds. Discovery of large databases of bioactive agents has been accelerated with high-throughput virtual screening utilizing quantum computing when determining further development priorities. Artificial intelligence and machine learning programs can take large data sets and determine patterns and correlations that help predict the properties of compounds and their biological activity. Molecular calculations derived from quantum mechanics give better approximations of noncovalent interactions and other quantum entities which are important in drug-target binding. The use of quantum computing to incorporate the methods of molecular dynamics simulations and QSAR analysis is empowering developments in pharmaceutical research. The review also overviews the modern concerns and possible opportunities of using quantum computing for the optimization of the drug discovery and development. All in all, the article presents a contingency of how this new and innovative technology is shaping the field of pharmaceutical research.
The integration of quantum computing in drug discovery has the potential to revolutionize pharmaceutical research by significantly enhancing molecular simulations, drug screening, and optimization processes. Traditional computational methods often struggle with the complexity of molecular interactions, leading to high costs and extended timelines in drug development. Quantum computing, with its ability to process complex calculations exponentially faster than classical computers, offers innovative solutions to these challenges. This chapter explores the fundamentals of quantum computing, its application in pharmaceutical research, and real-world case studies from leading organizations. It also discusses existing challenges, potential solutions, and future directions for adopting quantum computing in drug discovery. By addressing key technical, ethical, and regulatory aspects, this chapter provides a comprehensive analysis of how quantum technologies can accelerate and optimize the drug discovery pipeline.